Nina Hojs

682 total citations
32 papers, 517 citations indexed

About

Nina Hojs is a scholar working on Nephrology, Surgery and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Nina Hojs has authored 32 papers receiving a total of 517 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Nephrology, 11 papers in Surgery and 8 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Nina Hojs's work include Dialysis and Renal Disease Management (11 papers), Chronic Kidney Disease and Diabetes (9 papers) and Cardiovascular Health and Disease Prevention (5 papers). Nina Hojs is often cited by papers focused on Dialysis and Renal Disease Management (11 papers), Chronic Kidney Disease and Diabetes (9 papers) and Cardiovascular Health and Disease Prevention (5 papers). Nina Hojs collaborates with scholars based in Slovenia, United States and United Kingdom. Nina Hojs's co-authors include Radovan Hojs, Robert Ekart, Sebastjan Bevc, Nejc Piko, Ksenija Cankar, Martin Štrucl, Shuvo Roy, William H. Fissell, Mitja Kolar and Daniela Kniepeiss and has published in prestigious journals such as Clinical Journal of the American Society of Nephrology, Nephrology Dialysis Transplantation and Antioxidants.

In The Last Decade

Nina Hojs

31 papers receiving 504 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nina Hojs Slovenia 11 148 112 82 71 67 32 517
Christoph Hasslacher Germany 15 133 0.9× 127 1.1× 380 4.6× 113 1.6× 127 1.9× 49 676
Lukáš Pácal Czechia 15 86 0.6× 29 0.3× 103 1.3× 130 1.8× 51 0.8× 33 546
Mengjie Huang China 14 212 1.4× 69 0.6× 50 0.6× 159 2.2× 81 1.2× 32 570
Barbara S. Daniels United States 12 344 2.3× 108 1.0× 56 0.7× 130 1.8× 57 0.9× 14 610
Nejc Piko Slovenia 8 51 0.3× 53 0.5× 34 0.4× 41 0.6× 39 0.6× 30 273
Carolina Victória Cruz Junho Brazil 14 135 0.9× 101 0.9× 44 0.5× 207 2.9× 39 0.6× 24 533
Mona M. Salem Egypt 8 317 2.1× 44 0.4× 67 0.8× 133 1.9× 67 1.0× 23 500
In Jin Kim South Korea 15 170 1.1× 104 0.9× 82 1.0× 199 2.8× 52 0.8× 31 648
Dina O. Abdulazim Egypt 8 297 2.0× 39 0.3× 58 0.7× 128 1.8× 70 1.0× 27 478
Wei‐Zheng Zhang Australia 13 67 0.5× 157 1.4× 47 0.6× 160 2.3× 41 0.6× 25 566

Countries citing papers authored by Nina Hojs

Since Specialization
Citations

This map shows the geographic impact of Nina Hojs's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nina Hojs with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nina Hojs more than expected).

Fields of papers citing papers by Nina Hojs

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nina Hojs. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nina Hojs. The network helps show where Nina Hojs may publish in the future.

Co-authorship network of co-authors of Nina Hojs

This figure shows the co-authorship network connecting the top 25 collaborators of Nina Hojs. A scholar is included among the top collaborators of Nina Hojs based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nina Hojs. Nina Hojs is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ekart, Robert, et al.. (2025). Oxidative stress and inflammation in hemodialysis: a comparison of patients with or without advanced nonalcoholic fatty liver disease (NAFLD). Renal Failure. 47(1). 2455523–2455523. 2 indexed citations
2.
Hojs, Nina, et al.. (2024). Treatment of acute kidney injury with continuous renal replacement therapy and cytokine adsorber (CytoSorb®) in critically ill patients with COVID‐19. Therapeutic Apheresis and Dialysis. 28(6). 941–950. 4 indexed citations
3.
Hojs, Radovan, Robert Ekart, Sebastjan Bevc, & Nina Hojs. (2023). Chronic Kidney Disease and Obesity. ˜The œNephron journals/Nephron journals. 147(11). 660–664. 27 indexed citations
4.
Ekart, Robert, et al.. (2021). Early Detection of Arteriovenous Fistula Stenosis in Hemodialysis Patients through Routine Measurements of Dialysis Dose (Kt/V). Blood Purification. 51(1). 15–22. 3 indexed citations
5.
Hojs, Nina, Robert Ekart, Sebastjan Bevc, Nejc Piko, & Radovan Hojs. (2021). CHA<sub>2</sub>DS<sub>2</sub>-VASc Score as a Predictor of Cardiovascular and All-Cause Mortality in Chronic Kidney Disease Patients. American Journal of Nephrology. 52(5). 404–411. 9 indexed citations
6.
Hojs, Nina, et al.. (2021). Mineralocorticoid Receptor Antagonists in Diabetic Kidney Disease. Pharmaceuticals. 14(6). 561–561. 20 indexed citations
7.
Piko, Nejc, et al.. (2021). Diabetic patients with chronic kidney disease: Non-invasive assessment of cardiovascular risk. World Journal of Diabetes. 12(7). 975–996. 6 indexed citations
8.
Hojs, Nina, Sebastjan Bevc, Robert Ekart, & Radovan Hojs. (2020). Oxidative Stress Markers in Chronic Kidney Disease with Emphasis on Diabetic Nephropathy. Antioxidants. 9(10). 925–925. 128 indexed citations
9.
Hojs, Nina, et al.. (2020). Progression of endothelial dysfunction, atherosclerosis, and arterial stiffness in stable kidney transplant patients: a pilot study. BMC Cardiovascular Disorders. 20(1). 6–6. 9 indexed citations
10.
Ekart, Robert, Sebastjan Bevc, Nina Hojs, & Radovan Hojs. (2018). Derived Subendocardial Viability Ratio and Cardiovascular Events in Patients with Chronic Kidney Disease. Cardiorenal Medicine. 9(1). 41–50. 16 indexed citations
11.
Bevc, Sebastjan, et al.. (2018). Cystatin C as a predictor of mortality in elderly patients with chronic kidney disease. The Aging Male. 22(1). 62–67. 11 indexed citations
12.
Bevc, Sebastjan, Nina Hojs, Radovan Hojs, et al.. (2017). Estimation of Glomerular Filtration Rate in Elderly Chronic Kidney Disease Patients: Comparison of Three Novel Sophisticated Equations and Simple Cystatin C Equation. Therapeutic Apheresis and Dialysis. 21(2). 126–132. 5 indexed citations
13.
Hojs, Radovan, Robert Ekart, Sebastjan Bevc, & Nina Hojs. (2016). Markers of Inflammation and Oxidative Stress in the Development and Progression of Renal Disease in Diabetic Patients. ˜The œNephron journals/Nephron journals. 133(3). 159–162. 52 indexed citations
14.
Ekart, Robert, et al.. (2016). Subendocardial Viability Ratio Is Impaired in Highly Proteinuric Chronic Kidney Disease Patients With Low Estimated Glomerular Filtration Rate. Therapeutic Apheresis and Dialysis. 20(3). 281–285. 7 indexed citations
15.
Hojs, Radovan, Robert Ekart, Sebastjan Bevc, & Nina Hojs. (2015). Biomarkers of Renal Disease and Progression in Patients with Diabetes. Journal of Clinical Medicine. 4(5). 1010–1024. 36 indexed citations
16.
Ekart, Robert, et al.. (2015). Albuminuria is Associated With Subendocardial Viability Ratio in Chronic Kidney Disease Patients. Kidney & Blood Pressure Research. 40(6). 565–574. 29 indexed citations
17.
Ekart, Robert, Sebastjan Bevc, Radovan Hojs, & Nina Hojs. (2015). Proteinuria and Albuminuria During and After Paricalcitol Treatment in Chronic Kidney Disease Patients. The Journal of Clinical Pharmacology. 56(6). 761–768. 5 indexed citations
18.
Hojs, Nina, Sebastjan Bevc, Breda Pečovnik Balon, Radovan Hojs, & Robert Ekart. (2013). Paricalcitol Reduces Proteinuria in Non‐Dialysis Chronic Kidney Disease Patients. Therapeutic Apheresis and Dialysis. 17(4). 368–372. 5 indexed citations
19.
20.
Hojs, Nina, Martin Štrucl, & Ksenija Cankar. (2008). The effect of glibenclamide on acetylcholine and sodium nitroprusside induced vasodilatation in human cutaneous microcirculation. Clinical Physiology and Functional Imaging. 29(1). 38–44. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Christoph Hasslacher Breakdown of academic impact, for papers by Lukáš Pácal Breakdown of academic impact, for papers by Mengjie Huang Breakdown of academic impact, for papers by Barbara S. Daniels Breakdown of academic impact, for papers by Nejc Piko Breakdown of academic impact, for papers by Carolina Victória Cruz Junho Breakdown of academic impact, for papers by Mona M. Salem Breakdown of academic impact, for papers by In Jin Kim Breakdown of academic impact, for papers by Dina O. Abdulazim Breakdown of academic impact, for papers by Wei‐Zheng Zhang
Rankless by CCL
2026